Luo M, Ballester MP, Soffientini U, Jalan R, Mehta G. SARS-CoV-2 infection and liver involvement. Hepatol Int. 2022;16:755–774.

Article  PubMed  Google Scholar 

Akkiz H. Unraveling the molecular and cellular pathogenesis of COVID-19-associated liver injury. Viruses. 2023;15:1287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miranda C, Garlatti E, Da Porto A et al. Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update. Arch Med Sci Atheroscler Dis. 2023;8:e1–e10.

Article  PubMed  PubMed Central  Google Scholar 

Montori M, Baroni GS, Santori P et al. Liver damage and COVID-19: at least a “two-hit” story in systematic review. Curr Issues Mol Biol. 2023;45:3035–3047.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baldelli L, Marjot T, Barnes E, Barritt AS, Webb GJ, Moon AM. SARS-CoV-2 infection and liver disease: a review of pathogenesis and outcomes. Gut Liver. 2023;17:12–23.

Article  CAS  PubMed  Google Scholar 

Marjot T, Moon AM, Cook JA et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021;74:567–577.

Article  CAS  PubMed  Google Scholar 

Gonzalez HC, Nimri FM, Lu M et al. Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic. Hepatol Int. 2023. https://doi.org/10.1007/s12072-023-10569-y.

Article  PubMed  Google Scholar 

Gonzalez HC, Zhou Y, Nimri FM, Rupp LB, Trudeau S, Gordon SC. Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA. Liver Int. 2022;42:762–764.

Article  CAS  PubMed  Google Scholar 

Sohal A, Chaudhry H, Patel J et al. Impact of COVID-19 pandemic on alcohol-related hepatitis admissions: analysis of nationwide data 2016–2020. Am J Med Sci. 2023;366:209–218.

Article  PubMed  Google Scholar 

Nguyen VH, Kam L, Yeo YH et al. Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States. JAMA Netw Open. 2022;5:e2245424.

Article  PubMed  PubMed Central  Google Scholar 

Mohammed A, Paranji N, Chen PH, Niu B. COVID-19 in chronic liver disease and liver transplantation: a clinical review. J Clin Gastroenterol. 2021;55:187–194.

Article  PubMed  Google Scholar 

Twohig P, Schissel M, Samson K et al. Mortality increased among hospitalized patients with cirrhosis before and following different waves of the COVID-19 pandemic. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-023-08105-x.

Article  PubMed  Google Scholar 

University of Nebraska Medical Center. Universal COVID testing for admitted and transferred patients. https://www.nebraskamed.com/sites/default/files/documents/covid-19/universal-covid-admissions-screening-and-faq.pdf. Published 2020. Accessed August 17, 2023.

Kim D, Bonham CA, Konyn P, Cholankeril G, Ahmed A. Mortality trends in chronic liver disease and cirrhosis in the United States, before and during COVID-19 pandemic. Clin Gastroenterol Hepatol. 2021;19:2664-2666.e2662.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeo YH, He X, Lv F et al. Trends of cirrhosis-related mortality in the USA during the COVID-19 pandemic. J Clin Transl Hepatol. 2023;11:751–756.

PubMed  Google Scholar